| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 692580 | Null | 0.0171439890681608 | 0.52564069 |
| NSC 694000 | 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester | 0.0171439890681608 | 0.45177431 |
| NSC 694002 | 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester | 0.0171439890681608 | 0.49644846 |
| NSC 697886 | 17-Demethoxy-17-allylamino geldanamycin-11-[4-(dimethylamino)butyrate] | 0.0171439890681608 | 0.24761396 |
| NSC 698408 | Null | 0.0171439890681608 | 0.22524148 |
| NSC 700913 | Null | 0.0171439890681608 | 0.36553075 |
| NSC 702158 | 7-epi-3,4-bis-nor-dolastatin 11 | 0.0171439890681608 | 0.13611322 |
| NSC 714187 | 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate | 0.0171439890681608 | 0.20178128 |
| NSC 724058 | 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0171439890681608 | 0.25899836 |
| NSC 727987 | NSC 708783 incorporated in micelles, 0.20% (w/w) of drug | 0.0171439890681608 | 0.20631223 |